loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 125249 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 RILONACEPT (1)

filter

01 KINIKSA PHARMACEUTICALS (UK), LTD. (1)

filter

01 VIAL; SINGLE-USE (1)

filter

01 220MG (1)

filter

01 USA (1)

URL Supplier Web Content
VIAL; SINGLE-USE
220MG
ARCALYST
USA
125249
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 125249

Looking for CTD TGA MCC DOSSIER APPLICATION 125249 1

19

Kiniksa Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

One of their notable products is RILONACEPT, with a corresponding application number 125249 and regulatory information .

proudly manufactured in the

Kiniksa Pharmaceuticals's ARCALYST VIAL; SINGLE-USE, medication with 220MG of RILONACEPT.

Post Enquiry
POST ENQUIRY